AOD 9604: Unveiling the Potential of Fat Loss Peptide Therapy
AOD 9604, a synthetic fragment of growth hormone, has gained traction as a promising therapeutic agent for achieving fat loss. This compound exerts its effects by targeting adipose tissue, promoting the catabolism tb-500 peptides of triglycerides and minimizing lipogenesis, the process of fat synthesis. Preclinical studies have demonstrated AOD 960